Recently mRNA vaccines have received particular attention based on their effectiveness during the COVID-19 pandemic. Additionally, mRNA vaccines have achieved some promising clinical responses in treating a variety of solid tumours. However, other vaccine technologies have been under investigation for some time in immuno-oncology, too, including cell-based vaccines, dendritic cell-based vaccines, peptide vaccines, viral particle derived vaccines and DNA vaccines.